Fred Hutch Team Awarded $4.4M From the National Cancer Institute for Pioneering Immunogenic Cancer Research
Monday, August 5, 2013 - 16:00
in Health & Medicine
Scientists at Fred Hutchinson Cancer Research Center have received $4.4 million over four years from the National Cancer Institute to pioneer an ambitious new way to harness the power of the adaptive immune system to control cancer. The team is using high-throughput technology and emerging public data resources to help identify hundreds of proteins as possible immune targets and verify which ones might be immunogenic, i.e., capable of provoking an immune response in the body and therefore potentially useful in immune-based therapies.